Table 2.
Substance usea by colleagues.
| Respondents | No personal history of substance use (n = 988) | Personal history of substance use (n = 295) | p-value | |
|---|---|---|---|---|
| Known colleague substance use | 1053 (82.07) | 791 (80.06) | 261 (88.78) | 0.001 |
| Number of colleagues known to use | < 0.0001 | |||
| 1–2 | 325 (30.89) | 269 (34.05) | 56 (21.46) | |
| 3–5 | 477 (45.34) | 357 (45.19) | 119 (45.59) | |
| 6–10 | 140 (13.31) | 102 (12.91) | 38 (14.56) | |
| > 10 | 110 (10.46) | 62 (7.85) | 48 (18.39) | |
| Substances utilizedb | ||||
| Illicit stimulants | 339 (32.38) | 237 (30.19) | 101 (38.70) | 0.01 |
| Prescribed stimulants | 382 (36.49) | 222 (28.28) | 160 (61.30) | < 0.0001 |
| Anesthetic agents | 401 (38.30) | 311 (39.62) | 89 (34.10) | 0.11 |
| Opioids | 702 (67.05) | 576 (73.38) | 125 (47.89) | < 0.0001 |
| Marijuana | 548 (52.34) | 364 (46.37) | 183 (70.11) | < 0.0001 |
| Benzodiazepines | 420 (40.11) | 283 (36.05) | 137 (52.49) | < 0.0001 |
| Sleep induction/Maintenance medications | 478 (45.65) | 314 (40.00) | 164 (62.84) | < 0.0001 |
| Otherc | 26 (2.48) | 19 (2.42) | 7 (2.68) | 0.81 |
| Time when use observed | 0.001 | |||
| Both during and after residency | 571 (54.64) | 408 (52.04) | 163 (62.45) | |
| During residency | 196 (18.76) | 144 (18.37) | 52 (19.92) | |
| After residency | 278 (26.60) | 232 (29.59) | 46 (17.62) | |
| Colleague withdrawn from professional activities due to substance use | 737 (70.26) | 595 (75.60) | 142 (54.41) | < 0.0001 |
| Colleague returned to original professional activities | 0.56 | |||
| Yes | 282 (38.37) | 234 (39.39) | 48 (34.04) | |
| Yes, needed to withdraw later | 274 (37.28) | 221 (37.21) | 53 (37.59) | |
| Did not return | 92 (12.52) | 71 (11.95) | 21 (14.89) | |
| Unknown | 87 (11.84) | 68 (11.45) | 19 (13.48) | |
| Respondent believed their colleague might have increased their occupational hazard | 979 (93.15) | 757 (95.94) | 221 (84.67) | < 0.0001 |
| Respondent believed their colleague might have jeopardized patient safety | 923 (88.16) | 723 (91.87) | 199 (76.83) | < 0.0001 |
Data is presented as n (%).
Note: Substance use is defined as ‘ever used or uses any substance with the potential of abuse to change mental status.
Respondents could select all that apply.
Other included alcohol, diethylpropion, crack, ecstasy, gamma-hydroxybutyrate, lysergic acid diethylamide, methamphetamine, fentanyl, toluene inhalation, lisdexamfetamine;